Once again, a U.S. citizen is forced to travel overseas for an adult stem cell therapy which was pioneered by U.S. doctors but which is not available in the United States.
The FDA has lifted a halt that it imposed last month on a Phase II clinical trial conducted by Aastrom Biosciences, following an investigation into the death of a patient which was determined to be unrelated to the treatment.
Obama has abruptly dismissed the President’s Council on Bioethics, telling members of the Council that their services are no longer needed.
In an article entitled, "Adult Stem Cells are a Promising Market", investment analysts cite the many financial and scientific advantages of adult stem cells over embryonic stem cells.
The U.S. company NeoStem announces the signing of a new 10-year agreement with the Shanghai-based corporation Enhance BioMedical Holdings for the development of a network of adult stem cell treatment centers in China.
A new study sheds light on the ways by which damaged stem cells cause gray hair.
Toll Free:
1-800-980-STEM (7836)
Outside or Inside US Call:
1-954-358-3382
Toll Free Fax (US Only):
1-866-755-3951
From Outside US Fax:
1-775-887-1194
Copyright 2024, Stem Cell Insitute Panama. All rights reserved.
